ReviewDrug design, development and therapy2026
Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps.
Enes Erul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.